The CDC’s announcement that 2018 marked the United States’ fifth straight record-breaking year for cases of chlamydia, gonorrhea and syphilis was the week’s top story in infectious disease.
Other top stories included findings presented at IDWeek suggesting that more than half of measles cases in the first month of the New York state outbreak in 2018 were attributed to unvaccinated adults.
US sets another record for STDs, CDC says
Around 2.4 million cases of chlamydia, gonorrhea and syphilis were reported in the United States in 2018, marking the fifth straight record-breaking year for STDs in the country, the CDC announced. Read more.
51% of early cases in NY measles outbreak attributed to unvaccinated adults
Unvaccinated adults had a “significant” impact on the early days of the New York state measles outbreak, with 51% of cases during the first month being attributable to them, according to data presented at IDWeek. Read more.
RBX2660 safe, efficacious for recurrent C. difficile prevention
The investigational microbiota-based drug, RBX2660, safely and effectively prevented recurrent Clostridioides difficile infection, or rCDI, and demonstrated clinical durability 2 years after treatment, according to findings from the PUNCH open-label study presented at IDWeek. Read more.
‘Handshake stewardship’ effective and sustainable
Findings from an 8-year retrospective assessment of a handshake stewardship approach implemented at Children’s Hospital Colorado — characterized by team evaluation of prescribed antimicrobials and in-person feedback — showed that it is an effective and sustainable approach for stewardship efforts, researchers reported. Read more.
Study finds risk for false-negative rapid test results in HIV controllers
Rapid screening tests may not reliably diagnose HIV in natural HIV controllers, leading to false-negative test results in some patients, according to recently published study findings. Read more.